About Cytokine receptor-like factor 3
Cytokine receptor-like factor 3 (CRLF3) is a protein
from Homo sapiens identified by UniProt accession
Q8IUI8, 442 residues long.
MolForge cross-references it against 0 known binders and
164 disease associations.
Target properties
| Protein name | Cytokine receptor-like factor 3 |
| UniProt accession | Q8IUI8 |
| Gene | CRLF3 |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (164)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.38
- platelet component distribution width · score 0.37
- lymphocyte count · score 0.34
- mean platelet volume · score 0.34
- Red cell distribution width · score 0.28
- mean corpuscular volume · score 0.25
- forced expiratory volume · score 0.24
- mean corpuscular hemoglobin · score 0.24
- body height · score 0.24
- lymphocyte percentage of leukocytes · score 0.21
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IUI8-F1 | alphafold | PREDICTED | 89.67 | — |
Amino-acid sequence (442 residues)
MRGAMELEPE LLLQEARENV EAAQSYRREL GHRLEGLREA RRQIKESASQ TRDVLKQHFN DLKGTLGKLL DERLVTLLQE VDTIEQETIK PLDDCQKLIE HGVNTAEDLV REGEIAMLGG VGEENEKLWS FTKKASHIQL DSLPEVPLLV DVPCLSAQLD DSILNIVKDH IFKHGTVASR PPVQIEELIE KPGGIIVRWC KVDDDFTAQD YRLQFRKCTS NHFEDVYVGS ETEFIVLHID PNVDYQFRVC ARGDGRQEWS PWSVPQIGHS TLVPHEWTAG FEGYSLSSRR NIALRNDSES SGVLYSRAPT YFCGQTLTFR VETVGQPDRR DSIGVCAEKQ DGYDSLQRDQ AVCISTNGAV FVNGKEMTNQ LPAVTSGSTV TFDIEAVTLG TTSNNEGGHF KLRVTISSNN REVVFDWLLD QSCGSLYFGC SFFYPGWKVL VF
Explore Cytokine receptor-like factor 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets